Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AxelaCare Health Solutions is a leading provider of home infusion pharmacy services, specializing in the administration of complex intravenous therapies. The company focuses on treating chronic and acute conditions such as immune deficiencies, neurological disorders, and inflammatory diseases through its network of pharmacies and nursing services. AxelaCare is particularly known for its proprietary CarePlan technology, which tracks patient outcomes and clinical data to improve therapy management. The company provides a range of therapies including immunoglobulin (IVIG), antibiotics, and nutritional support. In 2015, the company was acquired by OptumRx, a division of UnitedHealth Group, to enhance its specialty pharmacy and home-based clinical capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AxelaCare Health Solutions.